| RQP73352 | |
| I. Introduction | |
Cell Line Name： | EML4-ALK V1 [L1196M/L1198F]/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
EML4-ALK results from the fusion of EML4 and ALK, resulting in constitutive kinase activity, transformation in cultured cells, and tumor activity in mouse models (PMID: 19064915, PMID: 17625570). EML4-ALK fusions have been associated with non-small cell lung cancer (PMID: 26755435). | |
| III. Representative Data | |
1.WB of EML4-ALK V1 [L1196M/L1198F]/BaF3
| |
2. Sanger of EML4-ALK V1 [L1196M/L1198F]/BaF3
Figure 1. EML4-ALK V1 [L1196M/L1198F]/BaF3 Fusion
Figure 2. EML4-ALK V1 [L1196M/L1198F]/BaF3 L1196M+L1198F | |
3. Anti-proliferation assay
Figure 3. CTG Proliferation Assay of BaF3 EML4-ALK V1 [L1196M/L1198F] (C1). | |
E-mail：sales@reqbio.com
Add:3rd Floor, No. 6, Lane 222,
Guangdan Road, Pudong New Area,
Shanghai，China
WeChat public account
